CAMP4 Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- CAMP4 Therapeutics's estimated annual revenue is currently $14.4M per year.
- CAMP4 Therapeutics's estimated revenue per employee is $155,000
- CAMP4 Therapeutics's total funding is $90M.
Employee Data
- CAMP4 Therapeutics has 93 Employees.
- CAMP4 Therapeutics grew their employee count by -8% last year.
CAMP4 Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP, Biology | Reveal Email/Phone |
2 | SVP, Discovery & Translation | Reveal Email/Phone |
3 | Senior Director, Discovery | Reveal Email/Phone |
4 | Associate Director, Lab Operations & Facilities | Reveal Email/Phone |
5 | Director Quality Assurance | Reveal Email/Phone |
6 | Chief People Officer | Reveal Email/Phone |
7 | Chief Scientific Officer | Reveal Email/Phone |
8 | Senior Director, Head Intellectual Property | Reveal Email/Phone |
9 | Associate Director, Head Discovery, CNS | Reveal Email/Phone |
10 | Director - Preclinical | Reveal Email/Phone |
CAMP4 Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is CAMP4 Therapeutics?
Founded in 2016 and focused on a core mission of realizing a world with ‘an effective treatment option for every patient,’ CAMP4 Therapeutics evolved from seminal discoveries made by company founders Dr. Richard Young and Dr. Leonard Zon, characterizing the ways in which dynamic cell signaling networks control the expression of genes. Operating at the intersection of genomics, computational biology and data sciences, CAMP4 has extended this foundational work, creating a unique Gene Circuitry Platform to amplify the value of cellular and genetic insights to better understand how genes are controlled by signaling pathways in specific disease states. By generating proprietary 4D maps, CAMP4 can identify de-risked druggable targets, produce actionable insights and improve therapeutic predictability, potentially addressing hundreds of diseases and benefiting millions of patients globally. Find out more at www.camp4tx.com.
keywords:N/A
$90M
Total Funding
93
Number of Employees
$14.4M
Revenue (est)
-8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
CAMP4 Therapeutics News
CAMP4 Therapeutics: Kelly Gold was named CFO of CAMP4. Gold currently serves as the company's chief business officer and SVP of finance.
IMAX, Omni, Convoy, Beachbody, Celsius, CNN, CAMP4 Therapeutics, Splash Beverage Group, Lummus Technology, Truepill. Lauren MuskettApril 22,...
BUSINESS WIRE)--CAMP4 Therapeutics, a biotechnology company harnessing the power of regulatory RNAs to upregulate genes and restore healthy...
CAMP4 Therapeutics, a biotechnology company harnessing the power of RNA to restore healthy gene expression, today announced that it has raised $45 million to propel the next phase of its scientific strategy, significantly expand its platform and advance multiple preclinical RNA therapies into hu ...
Camp4 Therapeutics, a Cambridge, MA-based platform to discover effective treatment approaches for every disease, raised $30M in Series A financing. The round was led by Andreessen Horowitz, with participation from Polaris Partners and The Kraft Group. The company intends to use the funds to ex ...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $19.1M | 93 | -5% | N/A |
#2 | $19.5M | 93 | 3% | N/A |
#3 | $13M | 93 | -13% | N/A |
#4 | $14.9M | 93 | 41% | N/A |
#5 | $15M | 93 | -7% | N/A |